Contact lenses

Mottet understands the concept of playing well and looking nice to boot.

“You have to look good when you’re playing.

You have these cute dresses and the shades.

You have to match,” said Mottet, with a chuckle.

Mottet’s talent and attire must have meshed because she won her singles match over Cassandra Hayne 10-8 at the No.

3 slot.

Schwenk encountered an 11-9 setback at No.

4 singles to the Trojans’ Kim Thorn.

Two of the better talents in the area, if not the state, took part in an exciting No.

1 doubles match that went the way of the Trojans.

Jennifer Bradfield and Thorn teamed up to defeat Stefanie Bauer and Jennifer Palmer 11-9.

Bradfield topped Bauer at No.

1 singles 10-5.

“It was good high school girls tennis.

I bet you wouldn’t find a better one in the state playing tonight.

It would have to be two good ones,” said Staggs, commenting about the No.

1 doubles match.

Bradfield was the fourth-place finisher at state in Class 1A singles a season ago.

This year a state title has to be on the top of her list.

“Jennifer has come out really strong.

She has worked hard over the winter.

This season she has put in more time than before.

She really wants it,” said Fairfield head coach Bill Sheppard, who is in h...

"He was, like, normal," Grewal, a 21-year-old accounting major, told the Tribune.

He said he went back to sleep but, according to authorities, Cho stayed awake.

"He did not seem like a guy that's capable of anything like this," Grewal said.

Cho had also shown recent signs of “violent, aberrant behaviour,” including the dorm fire and stalking women.

Authorities found a receipt for a Glock 9 millimetre handgun, bought on March 13, in Cho's backpack which also contained two knives and a cache of bullets, ABC reported.

He bought his second weapon, a .22 caliber pistol, within the last week.

Also in News Killer: Loner blamed for uni carnage Two hurt: White House shooting Amalgamations: Key review to slash jobs Connection: Tasmania shares pain Campus shootings: Delayed response costly Handguns: Call for ban hots up Rampage: Killer staggers college Massacre: Gunman identified Campus massacre: Obsession may have led to slaughter Campus massacre: You caused it, says final note Campus massacre: How killer bought weapon Gun debate: Shock despite violent history Campus massacre: Bush leads memorial Cute animals: Golf-playing parrot Disaster warning: Hospitals fail test Font size: + - Send this article: Print Email Have Your Say We welcome your comments on this story.

Comments are submitted for possible publication on th...

In the year-ago quarter, results were also boosted by an after-tax gain of $368 million from the breakup fee J&J received after medical device maker Guidant Corp.

backed out of an acquisition agreement and instead was purchased by Boston Scientific Corp.

Analysts surveyed by Thomson Financial had expected earnings per share of $1.05 and sales of $14.44 billion.

Sales totaled $15.04 billion, up nearly 16 percent from $12.99 billion a year earlier.

Operational sales growth, which excludes the impact of new products and currency exchange rates, was 6.3 percent.

Revenues from the medical devices and diagnostics division edged up 6.2 percent to $5.32 billion, hurt by a 14 percent slide at Cordis, J&J's cardiovascular device business.

Sales of Cordis' drug-coated stents, tiny metal scaffolds that prop open arteries and slowly release medicine, were problematic, Chief Financial Officer Dominic Caruso told analysts during a conference call.

He was referring to new concerns about the safety and effectiveness of J&J's Cypher and other drug-coated stents.

Caruso said J&J has already begun testing ways to integrate Conor Medsystems unique drug-delivery technology to improve its co...